Sulodexide (VESSEL) for the Prevention of Recurrent Venous Thromboembolism in Elderly Patients After a First Episode of Venous Thrombembolism
Latest Information Update: 02 Aug 2024
At a glance
- Drugs Sulodexide (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms Jason
Most Recent Events
- 30 Jul 2024 Planned End Date changed from 2 Sep 2023 to 2 Jan 2027.
- 30 Jul 2024 Planned primary completion date changed from 2 Aug 2020 to 31 Dec 2025.
- 26 Jun 2020 Planned End Date changed from 2 Dec 2023 to 2 Sep 2023.